|
PTPN12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.51279996810183E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.58810000050869E-07 |
| Normal-vs-Stage2 |
6.629100E-04 |
| Normal-vs-Stage3 |
1.224720E-03 |
| Normal-vs-Stage4 |
1.842420E-03 |
| Stage1-vs-Stage2 |
6.864600E-01 |
| Stage1-vs-Stage3 |
7.553400E-01 |
| Stage1-vs-Stage4 |
6.847600E-01 |
| Stage2-vs-Stage3 |
8.983400E-01 |
| Stage2-vs-Stage4 |
4.955400E-01 |
| Stage3-vs-Stage4 |
6.296000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16069995229162E-09 |
| Normal-vs-AfricanAmerican |
7.7408000000001E-05 |
| Normal-vs-Asian |
1.484440E-01 |
| Caucasian-vs-AfricanAmerican |
6.397800E-01 |
| Caucasian-vs-Asian |
9.720600E-01 |
| AfricanAmerican-vs-Asian |
8.326800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3164999979054E-08 |
| Normal-vs-Female |
7.99010000385181E-08 |
| Male-vs-Female |
8.656400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.464400E-03 |
| Normal-vs-Extreme_Weight |
4.11940000000222E-05 |
| Normal-vs-Obese |
8.35919999886414E-08 |
| Normal-vs-Extreme_Obese |
1.938580E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.115200E-01 |
| Normal_Weight-vs-Obese |
4.702400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.039600E-01 |
| Extreme_Weight-vs-Obese |
3.210200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.211600E-01 |
| Obese-vs-Extreme_Obese |
1.310190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.264720E-03 |
| Normal-vs-Age(41-60Yrs) |
1.0484002554989E-10 |
| Normal-vs-Age(61-80Yrs) |
2.02269999999283E-05 |
| Normal-vs-Age(81-100Yrs) |
2.297600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.549600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.707690E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.199800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.001650E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.540010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.202000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44189129922279E-12 |
| Normal-VS-Type2 PRCC |
1.167770E-01 |
| Normal-VS-KIRP CIMP |
3.356600E-03 |
| Normal-VS-Unclassified PRCC |
5.597000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.19739999973712E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.666100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.380800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.175500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.783300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.832100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.556400E-03 |
| Normal-vs-N1 |
3.954600E-04 |
| Normal-vs-N2 |
7.617400E-04 |
| N0-vs-N1 |
1.329740E-02 |
| N0-vs-N2 |
1.665830E-01 |
| N1-vs-N2 |
7.809600E-01 |
|
|
